Your browser doesn't support javascript.
loading
Access to Guideline-Recommended Pharmacogenomic Tests for Cancer Treatments: Experience of Providers and Patients.
Wu, Ann Chen; Mazor, Kathleen M; Ceccarelli, Rachel; Loomer, Stephanie; Lu, Christine Y.
Afiliação
  • Wu AC; Precision Medicine Translational Research (PROMoTeR) Center, Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, 401 Park Drive, Suite 401, Boston, MA 02215, USA. ann.wu@childrens.harvard.edu.
  • Mazor KM; Meyers Primary Care Institute, A Joint Endeavor of the University of Massachusetts Medical School, Reliant Medical Group and Fallon Health; 630 Plantation Street, Worcester, MA 02215, USA. Kathy.Mazor@meyersprimary.org.
  • Ceccarelli R; Precision Medicine Translational Research (PROMoTeR) Center, Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, 401 Park Drive, Suite 401, Boston, MA 02215, USA. rceccare@bu.edu.
  • Loomer S; Precision Medicine Translational Research (PROMoTeR) Center, Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, 401 Park Drive, Suite 401, Boston, MA 02215, USA. stephanie_loomer@harvardpilgrim.org.
  • Lu CY; Precision Medicine Translational Research (PROMoTeR) Center, Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, 401 Park Drive, Suite 401, Boston, MA 02215, USA. christine_lu@harvardpilgrim.org.
J Pers Med ; 7(4)2017 Nov 15.
Article em En | MEDLINE | ID: mdl-29140263

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Guideline / Qualitative_research Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Guideline / Qualitative_research Idioma: En Ano de publicação: 2017 Tipo de documento: Article